Ignite Creation Date:
2024-05-05 @ 11:33 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071253
Status:
TERMINATED
Last Update Posted:
2006-08-04
First Post:
2003-10-16
Brief Title:
Depakote Monotherapy Olanzapine Monotherapy and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A Randomized Double-Blind Study of Depakote Monotherapy Olanzapine Monotherapy and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
Status:
TERMINATED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the efficacy and safety of continued combination therapy using Depakote plus olanzapine vs Depakote monotherapy and olanzapine monotherapy in stable subjects during the maintenance phase of bipolar illness
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None